Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer

Genes Chromosomes and Cancer

Volumn 24, Issue 1, 1999, Pages 62-71

  Jonson, Tord ^a   Gorunova, Ludmila ^a   Dawiskiba, Sigmund ^a   Andrén Sandberg, Åke ^a   Stenman, Göran ^b   Ten Dijke, Peter ^c   Johansson, Bertil ^a   Höglund, Mattias ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 15Q; CHROMOSOME 18Q; CHROMOSOME DELETION; CLINICAL ARTICLE; COMPLEX FORMATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CLUSTER; GENE EXPRESSION; GENE INACTIVATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

AGED; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 18; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; TRANS-ACTIVATORS;

EID: 0032889954     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199901)24:1<62::AID-GCC9>3.0.CO;2-4     Document Type: Article

References (53)

1. Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin J-P, Järvinen H, Powell SM, Jen J, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B, de la Chapelle A. 1993. Clues to the pathogenesis of familial colorectal cancer. Science 260:812-816.
2. Barrett MT, Schutte M, Kern SE, Reid BJ. 1996. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res 56:4351-4353.
3. Bray-Ward P, Menninger J, Lieman J, Desai T, Mokady N, Banks A, Ward DC. 1996. FISH mapping of CEPH YAC clones. Genomics 32:1-14.
4. Brentnall TA, Chen R, Lee JG, Kimmey MB, Bronner MP, Haggitt RC, Kowdley KV, Hecker LM, Byrd DR. 1995. Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res 55:4264-4267.
5. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier J-M. 1998. Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17:3091-3100.
6. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui L-C, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L. 1996. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543-552.
7. Fazeli A, Dickinson SL, Hermiston ML, Tighe RV, Steen RG, Small CG, Stoeckli ET, Keino-Masu K, Masu M, Rayburn H, Simons J, Bronson RT, Gordon JI, Tessier-Lavigne M, Weinberg RA. 1997. Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene. Nature 386:796-804.
8. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B. 1990. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247:49-56.
9. Fukushige S, Waldman FM, Kimura M, Abe T, Furukawa T, Sunamura M, Kobari M, Horii A. 1997. Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer 19:161-169.
10. Fynan TM, Reiss M. 1993. Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis. Crit Rev Oncog 4:493-540.
11. Giacalone J, Li X, Lehrach H, Francke U. 1996. High-density radiation hybrid map of human chromosome 18 and contig of 18p. Genomics 37:9-18.
12. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA. 1995. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55:4531-4535.
13. Gorunova L, Höglund M, Andrén-Sandberg Å, Dawiskiba S, Jin Y, Mitelman F, Johansson B. 1998. Cytogenetic analysis of pancreatic-carcinomas: Intratumor heterogeneity and nonrandom pattern of chromosome aberrations. Genes Chromosomes Cancer 23:81-99.
14. Gotley DC, Reeder JA, Fawcett J, Walsh MD, Bates P, Simmons DL, Antalis TM. 1996. The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases. Oncogene 13:787-795.
15. Hahn SA, Seymour AB, Hoque ATMS, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. 1995. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 55:4670-4675.
16. Hahn SA, Hoque ATMS, Moskaluk CA, da Costa LT, Schutte M, Rozenblum E, Seymour AB, Weinstein CL, Yeo CJ, Hruban RH, Kern SE. 1996a. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 56:490-494.
17. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. 1996b. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353.
18. Han H-J, Yanagisawa A, Kato Y, Park J-G, Nakamura Y. 1993. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 53:5087-5089.
19. Hata A, Lagna G, Massagué J, Hemmati-Brivanlou A. 1998. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12:186-197.
20. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu Y-Y, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA Jr, Wrana JL, Falb D. 1997. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89:1165-1173.
21. Heldin C-H, Miyazono K, ten Dijke P. 1997. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471.
22. Höglund M, Gorunova L, Jonson T, Dawiskiba S, Andrén-Sandberg Å, Stenman G, Johansson B. 1998. Cytogenetic and FISH analyses of pancreatic carcinoma reveal breaks in 18q11 with consistent loss of 18q12-qter and frequent gain of 18p. Br J Cancer 77:1893-1899.
23. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J-I, Kawabata M, Miyazono K. 1997. Smad6 inhibits signalling by the TGF-β superfamily. Nature 389:622-626.
24. Kim SK, Fan Y, Papadimitrakopoulou V, Clayman G, Hittelman WN, Hong WK, Lotan R, Mao L. 1996. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and the neck squamous cell carcinoma. Cancer Res 56:2519-2521.
25. Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J. 1996. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 383:832-836.
26. Lei J, Zou T-T, Shi Y-Q, Zhou X, Smolinski KN, Yin J, Souza RF, Appel R, Wang S, Cymes K, Chan O, Abraham JM, Harpaz N, Meltzer SJ. 1996. Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms. Oncogene 13:2459-2462.
27. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. 1996. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87:1215-1224.
28. Mahlamäki EH, Höglund M, Gorunova L, Karhu R, Dawiskiba S, Andrén-Sandberg Å, Kallioniemi O-P, Johansson B. 1997. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer, Genes Chromosomes Cancer 20:383-391.
29. Massagué J, Hata A, Liu F. 1997. TGF-β signalling through the Smad pathway. Trends Cell Biol 7:187-192.
30. Meyerhardt JA, Look AT, Bigner SH, Fearon ER. 1997. Identification and characterization of neogenin, a DCC-related gene. Oncogene 14:1129-1136.
31. Nagatake M, Takagi Y, Osada H, Uchida K, Mitsudomi T, Saji S, Shimokata K, Takahashi T, Takahashi T. 1996. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 56:2718-2720.
32. Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawahata M, Heldin N-E, Heldin C-H, ten Dijke P. 1997a. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature 389:631-635.
33. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J-I, Heldin C-H, Miyazono K, ten Dijke P. 1997b. TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16:5353-5362.
34. Nakao A, Röijer E, Imamura T, Souchelnytskyi S, Stenman G, Heldin C-H, ten Dijke P. 1997c. Identification of Smad2, a human Mad-related protein in the transforming growth factor β signaling pathway. J Biol Chem 272:2896-2900.
35. Renault B, Calistri D, Buonsanti G, Nanni O, Amadori D, Ranzani GN. 1996. Microsatellite instability and mutations of p53 and TGF-β RII genes in gastric cancer. Hum Genet 98:601-607.
36. Riggins GJ, Thiagalingam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B. 1996. Mad-related genes in the human. Nat Genet 13:347-349.
37. Riggins GJ, Kinzler KW, Vogelstein B, Thiagalingam S. 1997. Frequency of Smad gene mutations in human cancers. Cancer Res 57:2578-2580.
38. Röijer E, Morén A, ten Dijke P, Stenman G. 1998. Assignment of the Smad7 gene (MADH7) to human chromosome 18q21.1 by fluorescence in situ hybridization. Cytogenet Cell Genet 81:189-190.
39. Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero RA Jr, Meltzer PS, Hahn SA, Kern SE. 1996. DPC4 gene in various tumor types. Cancer Res 56:2527-2530.
40. Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM. 1995. Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139:1347-1358.
41. Seymour AB, Hruban RH, Redston M, Caldas C, Powell SM, Kinzler KW, Yeo CJ, Kern SE. 1994. Allelotype of pancreatic adenocarcinoma. Cancer Res 54:2761-2764.
42. Shi Y, Hata A, Lo RS, Massagué J, Pavletich NP. 1997. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 388:87-93.
43. Solinas-Toldo S, Wallrapp C, Müller-Pillasch F, Bentz M, Gress T, Lichter P. 1996. Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 56:3803-3807.
44. Tahara H, Smith AP, Gaz RD, Cryns VL, Arnold A. 1996. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res 56:599-605.
45. Takagi Y, Kohmura H, Futamura M, Kida H, Tanemura H, Shimokawa K, Saji S. 1996. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 111:1369-1372.
46. Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JKV, Markowitz S, Hamilton SR, Kern SE, Kinzler KW, Vogelstein B. 1996. Evaluation of candidate tumor suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13:343-346.
47. Topper JN, Cai J, Qiu Y, Anderson KR, Xu Y-Y, Deeds JD, Feeley R, Gimeno CJ, Woolf EA, Tayber O, Mays GG, Sampson BA, Schoen FJ, Gimbrone MA Jr, Falb D. 1997. Vascular MADs: Two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci USA 94:9314-9319.
48. Uchida K, Nagatake M, Osada H, Yatabe Y, Kondo M, Mitsudomi T, Masuda A, Takahashi T, Takahashi T. 1996. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res 56:5583-5585.
49. Verbeek W, Spirin K, Hatta Y, Miller C, Kawamata N, Takeuchi S, Koike M, Asou H, Simpson JF, Koeffler HP. 1997. DPC4/SMAD4 in non-pancreatic tumors with frequent LOH 18q21 and in hematological malignancies. Int J Oncol 10:257-260.
50. Wick W, Petersen I, Schmutzler RK, Wolfarth B, Lenartz D, Bierhoff E, Hümmcrich J, Müller DJ, Stangl AP, Schramm J, Wiestler OD, von Deimling A. 1996. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. Oncogene 12:973-978.
51. Wu R-Y, Zhang Y, Feng X-H, Derynck R. 1997. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol Cell Biol 17:2521-2528.
52. Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT, Wang X-F. 1997. Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein. Mol Cell Biol 17:7019-7028.
53. Zhang Y, Feng X-H, Wu R-Y, Derynck R. 1996. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383:168-172.